Global AI in Drug Discovery Market to Reach US$ 3,547.4 Mn by 2031: Report

Date:

The global market for Artificial Intelligence in Drug Discovery is predicted to experience significant growth in the coming years. According to a recent report, the market was valued at US$ 1,016.1 million in 2024 and is expected to reach US$ 3,547.4 million by 2031, showing a compound annual growth rate (CAGR) of 5.7% between 2024 and 2031.

The report provides a detailed analysis of the market, covering aspects such as product pricing, market dynamics, key players, consumer behavior, and more. It also explores the opportunities available in the market at both the country and global levels.

Key players in the Artificial Intelligence in Drug Discovery Market include IBM Corporation, Exscientia, Alphabet Inc., and others. The report segments the market based on therapeutic space (such as oncology, neurodegenerative diseases, and cardiovascular diseases) and their applications (drug optimization & repurposing, preclinical testing, etc.).

Geographically, the market is divided into regions like North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The report also highlights the market’s competitive landscape, including the strengths, weaknesses, opportunities, and threats for the major players.

Overall, the report offers valuable insights into the market trends, growth drivers, and challenges, providing a comprehensive understanding of the Artificial Intelligence in Drug Discovery Market for the forecast period from 2024 to 2031.

See also  Revolutionary Device Enables Safe and Accurate Clinical Breast Examinations for Women

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Advait Gupta
Advait Gupta
Advait is our expert writer and manager for the Artificial Intelligence category. His passion for AI research and its advancements drives him to deliver in-depth articles that explore the frontiers of this rapidly evolving field. Advait's articles delve into the latest breakthroughs, trends, and ethical considerations, keeping readers at the forefront of AI knowledge.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.